Boiron

Compañía farmacéutica6 productos registrados

productos registrados

85.055

notificaciones totales

retiradas registradas

81,3%

graves en total

Productos

mostrando 6 de 6

Producto	Aprobado	Notificaciones ↓	Señal principal	Retiradas
ferrous sulfate —	1946	48.897	Enfermedad renal crónica	10
senna leaf —	—	22.469	Inmunodeficiencia	0
quinine —	2005	8945	Abuso de drogas	2
milk thistle —	—	4170	problema de sustitución del producto	0
cupric oxide —	—	572	Flatulencia vaginal	0
avobenzone 3%, homosalate 13%, octisalate 5%, octocrylene 10%, oxybenzone 6% —	—	2	—	0

Historial de retiradas · 12 registradas

Fecha	Clase	Motivo	Empresa
17 feb 2025	II	Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.	Safecor Health, LLC
26 abr 2023	II	CGMP Deviations: Firm went out of business and could no longer continue stability studies.	Akorn, Inc.
15 mar 2021	II	CGMP Deviations: Intermittent exposure to temperature excursion during storage.	Cardinal Health Inc.
31 may 2019	II	cGMP Deviations: Products may have microbial contamination.	Geritrex, LLC
31 may 2019	II	cGMP Deviations: Products may have microbial contamination.	Geritrex, LLC
7 may 2018	II	CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.	RIJ Pharmaceutical LLC
10 abr 2018	III	Presence of Foreign Tablets/Capsules	Aidarex Pharmaceuticals LLC
25 mar 2016	II	Lack of Processing Controls	Reliable Rexall-A Compounding Pharmacy
14 nov 2014	II	Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.	Attix Pharmaceuticals
2 jul 2013	II	Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron) may be potentially mislabeled as RAMIPRIL, Capsule, 2.5 mg, NDC 68180058901, Pedigree: AD54549_16, EXP: 5/20/2014.	Aidapak Services, LLC
2 jul 2013	II	Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe) may be potentially mislabeled as COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: W002711, EXP: 6/6/2014; VENLAFAXINE HCL, Tablet, 25 mg, NDC 00093019901, Pedigree: W002825, EXP: 12/31/2013; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD60236_1, EXP: 5/22/2014.	Aidapak Services, LLC
28 dic 2012	I	Labeling; Label Mixup; bottles of Ferrous Sulfate actually contains Meclizine HCl (indicated for motion sickness)	Advance Pharmaceutical Inc

Clase I = probabilidad razonable de daño grave · Clase II = temporal o reversible · Clase III = improbable que cause daño.

Estado de registro

Algunos productos de Boiron no están registrados por la FDA para uso humano. Para las sustancias no registradas (péptidos, SARM sin registro humano) no existe ningún proveedor legítimo para uso humano. La ausencia de una vía de aprovisionamiento es la información de seguridad.